Skip to main content Skip to main content
Not investment advice. Educational platform. See Disclaimer.
NYSE: SOLV

Solventum Corporation

Healthcare | Medical - Care Facilities
$78.27 +11.39 (+17.03%) as of 2026-07-14 18:01 UTC
Market Cap$13.6B
Volume1.32M
EPS (TTM)$8.88

Solventum Corporation (NYSE: SOLV) is a $13.6B medical - care facilities company trading at $78.27 (+17.0% today) — 8.8× trailing earnings. Figures from SEC EDGAR and market feeds; updated 2026-07-14 18:01 UTC.

52-Week Range
Low $65.17High $79.97

What Solventum Corporation does

Solventum is a global healthcare company that develops, manufactures, and commercializes solutions across medical surgery, dental, and healthcare software segments. The company serves hospitals, clinics, and dental practices with products spanning patient prevention, diagnosis, treatment, and recovery, including wound care, surgical supplies, dental products, and software for healthcare administration. With a history spanning over 70 years, Solventum leverages material science, data science, and digital capabilities to help customers improve patient outcomes and operational efficiency.

Summarized from Solventum Corporation’s SEC filings · Read the filing ↗

Key facts
Quote
Price$78.27
Change (1D)+11.39 (+17.03%)
Market cap$13.6B
Volume1.32M shares
52-week range$65.17 – $79.97
Valuation
P/E (TTM)8.81×
EV/EBITDA6.60×
EPS (TTM)$8.88
Price/book2.68×
Return on equity30.82%
Debt/equity1.00
Returns
52-week return+20.1%
Revenue, margins & earnings
FY2022 Net income: $1.34BFY2022 Taxes & interest: $350MFY2022 Operating expenses: $3.00BFY2022 Cost of revenue: $3.44B$8.13BFY2022FY2023 Net income: $1.35BFY2023 Taxes & interest: $346MFY2023 Operating expenses: $3.00BFY2023 Cost of revenue: $3.50B$8.20BFY2023FY2024 Net income: $479MFY2024 Taxes & interest: $557MFY2024 Operating expenses: $3.56BFY2024 Cost of revenue: $3.66B$8.25BFY2024FY2025 Net income: $1.56BFY2025 Taxes & interest: $625MFY2025 Operating expenses: $2.27BFY2025 Cost of revenue: $3.87B$8.32BFY2025
  • Net income
  • Taxes & interest
  • Operating expenses
  • Cost of revenue
Annual revenue; bands show net, operating, gross margins · Open in Platform →
SEC Filings SEC EDGAR ↗
Recent Insider Activity (last 90 days)
Source: SEC EDGAR · Filed 2026-05-18
  • 2026-05-18Wilson Darryl L.A3,300—
  • 2026-05-18Wendell Amy McBrideA3,300—
  • 2026-05-18WEILAND JOHN HA3,300—
Sign in to see all transactions →
Top Institutional Holders (latest 13F)
Source: SEC EDGAR · As of 2026-Q1
  • VANGUARD GROUP INC16,877,123$1.34B-1.4%
  • Independent Franchise Partners LLP15,733,495$1.03B+2.5%
  • VANGUARD CAPITAL MANAGEMENT LLC9,601,949$627.01MNEW
View QoQ ownership changes →
Company news View all →
Questions this page answers

What does Solventum Corporation do?

Solventum is a global healthcare company that develops, manufactures, and commercializes solutions across medical surgery, dental, and healthcare software segments.

What is SOLV's valuation?

SOLV trades at $78.27, 8.81× trailing earnings, 6.60× EV/EBITDA, as of 2026-07-14.

When did SOLV last file with the SEC?

Solventum Corporation's most recent SEC filing on record is a 8-K filed 2026-06-05. All filings link to their SEC EDGAR originals above.

Where does this data come from?

SEC EDGAR filings and public market data feeds, fetched 2026-07-14 18:01 UTC. This page is also available as JSON at /api/data?ticker=SOLV and is emitted with FAQPage structured data for machine reading.

For you

Charts, 10-year financials, peer comparison, screening and portfolio tracking for SOLV and 3,500+ tickers.

Create a free account — keep SOLV
For your agent
GET /api/data?ticker=SOLV

This page as JSON via rel="alternate" · REST API docs · MCP server (51 tools) · llms.txt